Introduction:

Adequate glycemic control in type-1 diabetes mellitus (DM) is essential. Interstitial glucose measurement (IGM) systems allow specific therapeutic adjustments. The aim of the study was to determine the impact of IGM systems in glycemic control in patients under 18 years with type-1 DM.

Material and methods:

Retrospective cohort study. Data were collected from medical records of the patient, as well as a survey of patients and their parents or guardians.

Results:

Of a total of 120 patients, 63 used an IGM system; after six months of use, a significant reduction (p < 0.05) in the glycated hemoglobin levels was observed, going from 7.5% ± 0.6 to 7.13% ± 0.47. In addition, there was a significant decrease in glycemic variability, in the number of capillary blood glucose levels and in the frequency of mild and severe hypoglycemia.

Conclusions:

The IGM systems help improve glycemic control in pediatric patients with type-1 DM.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )